Tapewire

Nasdaq · USD

TCMD

TACTILE SYSTEMS TECHNOLOGY INC

Export transactions ↓
Tapewire entity
5451
SEC CIK
0001027838
Parsed reports
468

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202601
Feb 202609
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 08, 2023 Filed May 10, 2023 20:22 UTC GrantCommon Stock 7,737 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-013617 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,151

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 08, 2023 Filed May 10, 2023 20:18 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 786 $18.65 $14,658.98
Disclosure

SEC source: 0001437749-23-013611 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,562

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 08-31-2021.

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
May 08, 2023 Filed May 10, 2023 20:17 UTC
PAULS ERICSenior VP, Sales
SaleCommon Stock 550 $18.55 $10,199.92
Disclosure

SEC source: 0001437749-23-013608 · rdgdoc.xml · nonDerivative · entry 1

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,498

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-15-2021.

F2 · price: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:06 UTC
Moen BrentChief Financial Officer
SaleCommon Stock 1,391 $14.10 $19,613.10
Disclosure

SEC source: 0001437749-23-005373 · rdgdoc.xml · nonDerivative · entry 1

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,760

F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 01:36 UTC
REUVERS DANIEL L.Director · President and CEO
SaleCommon Stock 700 $14.56 $10,188.99
Disclosure

SEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 3

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,715

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F4 · price: Reflects the weighted average price of 700 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.55 to $14.56 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 01:35 UTC
Moen BrentChief Financial Officer
SaleCommon Stock 251 $14.58 $3,660.28
Disclosure

SEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 3

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,151

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F4 · price: Reflects the weighted average price of 251 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.5813 to $14.585 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 01:34 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 135 $14.58 $1,968.30
Disclosure

SEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,348

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 01:32 UTC
PAULS ERICSenior VP, Sales
SaleCommon Stock 72 $14.54 $1,046.83
Disclosure

SEC source: 0001437749-23-004975 · rdgdoc.xml · nonDerivative · entry 3

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,048

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 72 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.53 to $14.54 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 01:36 UTC
REUVERS DANIEL L.Director · President and CEO
SaleCommon Stock 6,387 $15.27 $97,532.68
Disclosure

SEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 2

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,415

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 6,387 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.00 to $15.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 01:35 UTC
Moen BrentChief Financial Officer
SaleCommon Stock 3,801 $15.36 $58,398.56
Disclosure

SEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 2

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,402

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 3,801 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.345 to $15.375 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 01:34 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 2,162 $15.39 $33,275.56
Disclosure

SEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,483

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 2,162 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.3714 to $15.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 01:32 UTC
PAULS ERICSenior VP, Sales
SaleCommon Stock 1,401 $15.33 $21,477.33
Disclosure

SEC source: 0001437749-23-004975 · rdgdoc.xml · nonDerivative · entry 2

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,120

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

Read SEC document
February 25, 2023 Filed Mar 1, 2023 01:36 UTC
REUVERS DANIEL L.Director · President and CEO
GrantCommon Stock 6,482 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,802

F1 · shares: On February 25, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 6,482 PSUs. Of those earned PSUs, one-third, or 2,161 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 4,321 PSUs, are scheduled to vest on February 25, 2024.

Read SEC document
February 25, 2023 Filed Mar 1, 2023 01:35 UTC
Moen BrentChief Financial Officer
GrantCommon Stock 2,304 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 1

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,203

F1 · shares: On February 25, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 2,304 PSUs. Of those earned PSUs, one-third, or 768 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 1,536 PSUs, are scheduled to vest on February 25, 2024.

Read SEC document
February 25, 2023 Filed Mar 1, 2023 01:34 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 962 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,645

F1 · shares: On May 5, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 962 PSUs. Of those earned PSUs, one-third, or 320 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 642 PSUs, are scheduled to vest on February 25, 2024.

Read SEC document
February 25, 2023 Filed Mar 1, 2023 01:32 UTC
PAULS ERICSenior VP, Sales
GrantCommon Stock 595 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004975 · rdgdoc.xml · nonDerivative · entry 1

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,521

F1 · shares: On May 5, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 595 PSUs. Of those earned PSUs, one-third, or 198 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 397 PSUs, are scheduled to vest on February 25, 2024.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:43 UTC GrantCommon Stock 3,414 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004566 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,414

F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2023.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:42 UTC
REUVERS DANIEL L.Director · President and CEO
GrantCommon Stock 52,613 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004565 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,320

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:40 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 16,724 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004564 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,683

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:40 UTC
PAULS ERICSenior VP, Sales
GrantCommon Stock 12,627 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004563 · rdgdoc.xml · nonDerivative · entry 1

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,926

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 21:12 UTC
REUVERS DANIEL L.Director · President and CEO
SaleCommon Stock 1,020 $9.18 $9,363.70
Disclosure

SEC source: 0001437749-22-019830 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,707

F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
August 04, 2022 Filed Aug 8, 2022 20:56 UTC PurchaseCommon Stock 4,900 $9.15 $44,835.00
Disclosure

SEC source: 0001437749-22-019396 · rdgdoc.xml · nonDerivative · entry 1

BURKE WILLIAM W · CIK 0001200612 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,436

F1 · price: Reflects the weighted average price of 4,900 shares of common stock of Tactile Systems Technology, Inc. purchased by the reporting person in multiple transactions on August 4, 2022 with sale prices ranging from $9.14 to $9.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2022 Filed May 23, 2022 22:41 UTC SaleCommon Stock 1,100 $10.12 $11,132.00
Disclosure

SEC source: 0001437749-22-013333 · rdgdoc.xml · nonDerivative · entry 1

BURKE WILLIAM W · CIK 0001200612 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,536

F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021.

Read SEC document
May 09, 2022 Filed May 11, 2022 21:40 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-011964 · rdgdoc.xml · nonDerivative · entry 1

Asbury Valerie L. · CIK 0001904264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,538

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 09, 2022 Filed May 11, 2022 21:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-011961 · rdgdoc.xml · nonDerivative · entry 1

BURKE WILLIAM W · CIK 0001200612 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,636

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 09, 2022 Filed May 11, 2022 21:39 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-011963 · rdgdoc.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,538

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 09, 2022 Filed May 11, 2022 21:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-011960 · rdgdoc.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,448

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 09, 2022 Filed May 11, 2022 21:28 UTC
Jain DeeptiDirector
GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-011959 · rdgdoc.xml · nonDerivative · entry 1

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,448

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 09, 2022 Filed May 11, 2022 21:24 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-011955 · rdgdoc.xml · nonDerivative · entry 1

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,036

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2022 Filed May 10, 2022 20:32 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 999 $13.04 $13,022.56
Disclosure

SEC source: 0001437749-22-011765 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,959

F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 999 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 6, 2022 with sale prices ranging from $13.0219 to $13.064 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 06, 2022 Filed May 10, 2022 20:29 UTC
PAULS ERICSenior VP, Sales
SaleCommon Stock 600 $13.03 $7,819.08
Disclosure

SEC source: 0001437749-22-011759 · rdgdoc.xml · nonDerivative · entry 1

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,299

F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 600 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 6, 2022 with sale prices ranging from $13.0223 to $13.065 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 21:35 UTC
Moen BrentChief Financial Officer
SaleCommon Stock 176 $20.64 $3,633.06
Disclosure

SEC source: 0001437749-22-005696 · rdgdoc.xml · nonDerivative · entry 1

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,899

F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019.

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:00 UTC
Moen BrentChief Financial Officer
SaleCommon Stock 1,632 $20.33 $33,179.38
Disclosure

SEC source: 0001437749-22-005171 · rdgdoc.xml · nonDerivative · entry 1

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,075

F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 01:27 UTC
REUVERS DANIEL L.Director · President and CEO
SaleCommon Stock 877 $19.78 $17,350.39
Disclosure

SEC source: 0001437749-22-004756 · rdgdoc.xml · nonDerivative · entry 2

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,727

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 01:25 UTC
Moen BrentChief Financial Officer
SaleCommon Stock 624 $19.85 $12,383.28
Disclosure

SEC source: 0001437749-22-004754 · rdgdoc.xml · nonDerivative · entry 2

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,707

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 01:27 UTC
REUVERS DANIEL L.Director · President and CEO
GrantCommon Stock 53,937 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-004756 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,604

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 01:25 UTC
Moen BrentChief Financial Officer
GrantCommon Stock 29,126 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-004754 · rdgdoc.xml · nonDerivative · entry 1

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,331

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 01:21 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 16,181 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-004751 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,958

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 01:20 UTC
PAULS ERICSenior VP, Sales
GrantCommon Stock 12,944 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-004749 · rdgdoc.xml · nonDerivative · entry 1

PAULS ERIC · CIK 0001857667 · Senior VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,899

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 21:10 UTC GrantCommon Stock 2,435 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-004613 · rdgdoc.xml · nonDerivative · entry 1

Asbury Valerie L. · CIK 0001904264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,435

F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2022.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 21:08 UTC GrantCommon Stock 2,435 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-004610 · rdgdoc.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,435

F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2022.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:03 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 6,391 $0.00 Strike: $21.68 $0.00
Disclosure

SEC source: 0001437749-21-023296 · rdgdoc.xml · derivative · entry 6

ROCHE KEVIN H · CIK 0001024356 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,391 shares

Expires 2024-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:03 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 14,370 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001437749-21-023296 · rdgdoc.xml · derivative · entry 5

ROCHE KEVIN H · CIK 0001024356 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,370 shares

Expires 2023-07-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:03 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 4,994 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001437749-21-023296 · rdgdoc.xml · derivative · entry 4

ROCHE KEVIN H · CIK 0001024356 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,994 shares

Expires 2022-12-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:03 UTC Exercise / conversionCommon Stock 6,391 $21.68 $138,556.88
Disclosure

SEC source: 0001437749-21-023296 · rdgdoc.xml · nonDerivative · entry 3

ROCHE KEVIN H · CIK 0001024356 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:03 UTC Exercise / conversionCommon Stock 14,370 $10.00 $143,700.00
Disclosure

SEC source: 0001437749-21-023296 · rdgdoc.xml · nonDerivative · entry 2

ROCHE KEVIN H · CIK 0001024356 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:03 UTC Exercise / conversionCommon Stock 4,994 $0.68 $3,395.92
Disclosure

SEC source: 0001437749-21-023296 · rdgdoc.xml · nonDerivative · entry 1

ROCHE KEVIN H · CIK 0001024356 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2021 Filed Sep 7, 2021 20:17 UTC
Moen BrentChief Financial Officer
Tax withholdingCommon Stock 486 $44.87 $21,806.82
Disclosure

SEC source: 0001437749-21-021567 · rdgdoc.xml · nonDerivative · entry 1

Moen Brent · CIK 0001512710 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,205

F1 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock units.

Read SEC document
August 06, 2021 Filed Aug 9, 2021 14:30 UTC
REUVERS DANIEL L.Director · President and CEO
SaleCommon Stock 1,063 $43.11 $45,828.16
Disclosure

SEC source: 0001437749-21-019032 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,667

F1 · shares: The shares were sold to cover taxes associated with the settlement of restricted stock units.

F2 · price: Reflects the weighted average price of 1,063 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on August 6, 2021 with sale prices ranging from $43.10 to $43.1622 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 07, 2021 Filed Jul 7, 2021 20:05 UTC
REUVERS DANIEL L.Director · President and CEO
SaleCommon Stock 2,961 $49.75 $147,319.82
Disclosure

SEC source: 0001437749-21-016567 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,730

F1 · shares: The shares were sold to cover taxes associated with the settlement of restricted stock units.

F2 · price: Reflects the weighted average price of 2,961 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on July 7, 2021 with sale prices ranging from $49.74 to $49.839 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.